[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware (State or other jurisdiction of incorporation or organization) | 36-6169860 (I.R.S. Employer Identification No.) |
333 S. Wabash Chicago, Illinois (Address of principal executive offices) | 60604 (Zip Code) |
Large accelerated filer [x] | Accelerated filer [ ] | Non-accelerated filer [ ] (Do not check if a smaller reporting company) | Smaller reporting company [ ] |
Class | Outstanding at October 26, 2012 | |
Common Stock, Par value $2.50 | 269,397,139 |
Item Number | PART I. Financial Information | Page Number |
1. | ||
2. | ||
3. | ||
4. | ||
PART II. Other Information | ||
1. | ||
4. | ||
6. |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions, except per share data) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Revenues | |||||||||||||||
Net earned premiums | $ | 1,781 | $ | 1,732 | $ | 5,098 | $ | 4,942 | |||||||
Net investment income | 601 | 394 | 1,719 | 1,531 | |||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests: | |||||||||||||||
Other-than-temporary impairment losses | (62 | ) | (75 | ) | (89 | ) | (136 | ) | |||||||
Portion of other-than-temporary impairments recognized in Other comprehensive income | (2 | ) | (2 | ) | (25 | ) | (44 | ) | |||||||
Net other-than-temporary impairment losses recognized in earnings | (64 | ) | (77 | ) | (114 | ) | (180 | ) | |||||||
Other net realized investment gains | 72 | 50 | 180 | 181 | |||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | 8 | (27 | ) | 66 | 1 | ||||||||||
Other revenues | 76 | 76 | 230 | 214 | |||||||||||
Total revenues | 2,466 | 2,175 | 7,113 | 6,688 | |||||||||||
Claims, Benefits and Expenses | |||||||||||||||
Insurance claims and policyholders’ benefits | 1,435 | 1,400 | 4,164 | 4,131 | |||||||||||
Amortization of deferred acquisition costs | 333 | 297 | 937 | 880 | |||||||||||
Other operating expenses | 341 | 311 | 976 | 914 | |||||||||||
Interest | 43 | 43 | 128 | 132 | |||||||||||
Total claims, benefits and expenses | 2,152 | 2,051 | 6,205 | 6,057 | |||||||||||
Income from continuing operations before income tax | 314 | 124 | 908 | 631 | |||||||||||
Income tax expense | (93 | ) | (48 | ) | (271 | ) | (196 | ) | |||||||
Income from continuing operations | 221 | 76 | 637 | 435 | |||||||||||
Loss from discontinued operations, net of income tax benefit of -, -, - and $0 | — | — | — | (1 | ) | ||||||||||
Net income | 221 | 76 | 637 | 434 | |||||||||||
Net (income) loss attributable to noncontrolling interests | — | (1 | ) | — | (15 | ) | |||||||||
Net income attributable to CNA | $ | 221 | $ | 75 | $ | 637 | $ | 419 | |||||||
Income Attributable to CNA Common Stockholders | |||||||||||||||
Income from continuing operations attributable to CNA common stockholders | $ | 221 | $ | 75 | $ | 637 | $ | 420 | |||||||
Loss from discontinued operations attributable to CNA common stockholders | — | — | — | (1 | ) | ||||||||||
Income attributable to CNA common stockholders | $ | 221 | $ | 75 | $ | 637 | $ | 419 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions, except per share data) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Basic Earnings Per Share Attributable to CNA Common Stockholders | |||||||||||||||
Income from continuing operations attributable to CNA common stockholders | $ | 0.82 | $ | 0.28 | $ | 2.37 | $ | 1.56 | |||||||
Loss from discontinued operations attributable to CNA common stockholders | — | — | — | — | |||||||||||
Income attributable to CNA common stockholders | $ | 0.82 | $ | 0.28 | $ | 2.37 | $ | 1.56 | |||||||
Diluted Earnings Per Share Attributable to CNA Common Stockholders | |||||||||||||||
Income from continuing operations attributable to CNA common stockholders | $ | 0.82 | $ | 0.28 | $ | 2.36 | $ | 1.56 | |||||||
Loss from discontinued operations attributable to CNA common stockholders | — | — | — | — | |||||||||||
Income attributable to CNA common stockholders | $ | 0.82 | $ | 0.28 | $ | 2.36 | $ | 1.56 | |||||||
Dividends per share | $ | 0.15 | $ | 0.10 | $ | 0.45 | $ | 0.30 | |||||||
Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||||||||||||||
Basic | 269.4 | 269.3 | 269.4 | 269.3 | |||||||||||
Diluted | 269.8 | 269.6 | 269.8 | 269.6 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Other Comprehensive Income, Net of Tax | |||||||||||||||
Changes in: | |||||||||||||||
Net unrealized gains (losses) on investments with other-than-temporary impairments | $ | 36 | $ | (14 | ) | $ | 73 | $ | 25 | ||||||
Net unrealized gains on other investments | 191 | 236 | 530 | 558 | |||||||||||
Net unrealized gains on investments | 227 | 222 | 603 | 583 | |||||||||||
Foreign currency translation adjustment | 33 | (52 | ) | 37 | (22 | ) | |||||||||
Pension and postretirement benefits | 3 | 1 | 12 | 3 | |||||||||||
Net unrealized gains on discontinued operations and other | — | — | — | 1 | |||||||||||
Allocation to participating policyholders | — | (6 | ) | (2 | ) | (7 | ) | ||||||||
Other comprehensive income, net of tax | 263 | 165 | 650 | 558 | |||||||||||
Net income | 221 | 76 | 637 | 434 | |||||||||||
Comprehensive income | 484 | 241 | 1,287 | 992 | |||||||||||
Other comprehensive (income) loss attributable to noncontrolling interests related to changes in net unrealized (gains) losses on investments | — | — | — | (8 | ) | ||||||||||
Net (income) loss attributable to noncontrolling interests | — | (1 | ) | — | (15 | ) | |||||||||
Comprehensive (income) loss attributable to noncontrolling interests | — | (1 | ) | — | (23 | ) | |||||||||
Total comprehensive income attributable to CNA | $ | 484 | $ | 240 | $ | 1,287 | $ | 969 |
September 30, 2012 | December 31, 2011 | ||||||
(In millions, except share data) | |||||||
Assets | |||||||
Investments: | |||||||
Fixed maturity securities at fair value (amortized cost of $37,945 and $37,345) | $ | 42,305 | $ | 39,937 | |||
Equity securities at fair value (cost of $228 and $288) | 260 | 304 | |||||
Limited partnership investments | 2,370 | 2,245 | |||||
Other invested assets | 11 | 12 | |||||
Mortgage loans | 358 | 234 | |||||
Short term investments | 2,484 | 1,641 | |||||
Total investments | 47,788 | 44,373 | |||||
Cash | 129 | 75 | |||||
Reinsurance receivables (less allowance for uncollectible receivables of $74 and $91) | 5,840 | 6,001 | |||||
Insurance receivables (less allowance for uncollectible receivables of $102 and $112) | 1,902 | 1,614 | |||||
Accrued investment income | 484 | 436 | |||||
Deferred acquisition costs | 603 | 552 | |||||
Deferred income taxes | 8 | 415 | |||||
Property and equipment at cost (less accumulated depreciation of $408 and $420) | 317 | 309 | |||||
Goodwill and other intangible assets | 285 | 139 | |||||
Other assets (includes $0 and $130 due from Loews Corporation) | 911 | 779 | |||||
Separate account business | 345 | 417 | |||||
Total assets | $ | 58,612 | $ | 55,110 | |||
Liabilities and Equity | |||||||
Liabilities: | |||||||
Insurance reserves: | |||||||
Claim and claim adjustment expenses | $ | 24,331 | $ | 24,303 | |||
Unearned premiums | 3,681 | 3,250 | |||||
Future policy benefits | 10,974 | 9,810 | |||||
Policyholders’ funds | 165 | 191 | |||||
Participating policyholders’ funds | 71 | 68 | |||||
Short term debt | 13 | 83 | |||||
Long term debt | 2,557 | 2,525 | |||||
Other liabilities (includes $87 and $0 due to Loews Corporation) | 3,815 | 2,975 | |||||
Separate account business | 345 | 417 | |||||
Total liabilities | 45,952 | 43,622 | |||||
Commitments and contingencies (Notes D, H and J) | |||||||
Equity: | |||||||
Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 269,397,139 and 269,274,900 shares outstanding) | 683 | 683 | |||||
Additional paid-in capital | 2,144 | 2,141 | |||||
Retained earnings | 8,823 | 8,308 | |||||
Accumulated other comprehensive income | 1,130 | 480 | |||||
Treasury stock (3,643,104 and 3,765,343 shares), at cost | (99 | ) | (102 | ) | |||
Notes receivable for the issuance of common stock | (21 | ) | (22 | ) | |||
Total CNA stockholders’ equity | 12,660 | 11,488 | |||||
Total liabilities and equity | $ | 58,612 | $ | 55,110 |
Nine months ended September 30 | |||||||
(In millions) | 2012 | 2011 | |||||
Cash Flows from Operating Activities | |||||||
Net income | $ | 637 | $ | 434 | |||
Adjustments to reconcile net income to net cash flows provided by operating activities: | |||||||
Loss from discontinued operations | — | 1 | |||||
Loss on disposal of property and equipment | 1 | 8 | |||||
Deferred income tax expense | 95 | 151 | |||||
Trading portfolio activity | (13 | ) | (8 | ) | |||
Net realized investment gains, net of participating policyholders’ interests | (66 | ) | (1 | ) | |||
Equity method investees | (68 | ) | 80 | ||||
Amortization of investments | (43 | ) | (47 | ) | |||
Depreciation and amortization | 83 | 59 | |||||
Changes in: | |||||||
Receivables, net | 348 | 267 | |||||
Accrued investment income | (46 | ) | (42 | ) | |||
Deferred acquisition costs | (27 | ) | (21 | ) | |||
Insurance reserves | (53 | ) | (5 | ) | |||
Other assets | 90 | 110 | |||||
Other liabilities | 47 | (181 | ) | ||||
Other, net | 8 | 10 | |||||
Total adjustments | 356 | 381 | |||||
Net cash flows provided by operating activities-continuing operations | $ | 993 | $ | 815 | |||
Net cash flows provided (used) by operating activities-discontinued operations | $ | — | $ | (2 | ) | ||
Net cash flows provided by operating activities-total | $ | 993 | $ | 813 | |||
Cash Flows from Investing Activities | |||||||
Purchases of fixed maturity securities | $ | (7,369 | ) | $ | (8,854 | ) | |
Proceeds from fixed maturity securities: | |||||||
Sales | 4,761 | 5,900 | |||||
Maturities, calls and redemptions | 2,655 | 2,434 | |||||
Purchases of equity securities | (30 | ) | (51 | ) | |||
Proceeds from sales of equity securities | 72 | 171 | |||||
Origination of mortgage loans | (129 | ) | (118 | ) | |||
Change in short term investments | (505 | ) | 499 | ||||
Change in other investments | 35 | (137 | ) | ||||
Purchase of Hardy | (197 | ) | — | ||||
Purchases of property and equipment | (60 | ) | (67 | ) | |||
Other, net | 20 | 4 | |||||
Net cash flows used by investing activities-continuing operations | $ | (747 | ) | $ | (219 | ) | |
Net cash flows provided (used) by investing activities-discontinued operations | $ | — | $ | 2 | |||
Net cash flows used by investing activities-total | $ | (747 | ) | $ | (217 | ) |
Nine months ended September 30 | |||||||
(In millions) | 2012 | 2011 | |||||
Cash Flows from Financing Activities | |||||||
Acquisition of CNA Surety noncontrolling interest | $ | — | $ | (475 | ) | ||
Dividends paid to common stockholders | (122 | ) | (81 | ) | |||
Proceeds from the issuance of debt | — | 396 | |||||
Repayment of debt | (70 | ) | (420 | ) | |||
Stock options exercised | 1 | 2 | |||||
Other, net | (4 | ) | (10 | ) | |||
Net cash flows used by financing activities-continuing operations | $ | (195 | ) | $ | (588 | ) | |
Net cash flows provided (used) by financing activities-discontinued operations | $ | — | $ | — | |||
Net cash flows used by financing activities-total | $ | (195 | ) | $ | (588 | ) | |
Effect of foreign exchange rate changes on cash | $ | 3 | $ | (1 | ) | ||
Net change in cash | $ | 54 | $ | 7 | |||
Cash, beginning of year | 75 | 77 | |||||
Cash, end of period | $ | 129 | $ | 84 |
Nine months ended September 30 | |||||||
(In millions) | 2012 | 2011 | |||||
Common Stock | |||||||
Balance, beginning of period | $ | 683 | $ | 683 | |||
Balance, end of period | 683 | 683 | |||||
Additional Paid-in Capital | |||||||
Balance, beginning of period, as previously reported | 2,146 | 2,200 | |||||
Cumulative effect adjustment from accounting change for deferred acquisition costs, net of tax | (5 | ) | — | ||||
Balance, beginning of period, as adjusted | 2,141 | 2,200 | |||||
Stock-based compensation | 3 | 3 | |||||
Acquisition of CNA Surety noncontrolling interest | — | (65 | ) | ||||
Other | — | 1 | |||||
Balance, end of period | 2,144 | 2,139 | |||||
Retained Earnings | |||||||
Balance, beginning of period, as previously reported | 8,382 | 7,876 | |||||
Cumulative effect adjustment from accounting change for deferred acquisition costs, net of tax | (74 | ) | (72 | ) | |||
Balance, beginning of period, as adjusted | 8,308 | 7,804 | |||||
Dividends paid to common stockholders | (122 | ) | (81 | ) | |||
Net income attributable to CNA | 637 | 419 | |||||
Balance, end of period | 8,823 | 8,142 | |||||
Accumulated Other Comprehensive Income | |||||||
Balance, beginning of period, as previously reported | 470 | 326 | |||||
Cumulative effect adjustment from accounting change for deferred acquisition costs, net of tax | 10 | — | |||||
Balance, beginning of period, as adjusted | 480 | 326 | |||||
Other comprehensive income attributable to CNA | 650 | 550 | |||||
Acquisition of CNA Surety noncontrolling interest | — | 19 | |||||
Balance, end of period | 1,130 | 895 | |||||
Treasury Stock | |||||||
Balance, beginning of period | (102 | ) | (105 | ) | |||
Stock-based compensation | 3 | 3 | |||||
Balance, end of period | (99 | ) | (102 | ) | |||
Notes Receivable for the Issuance of Common Stock | |||||||
Balance, beginning of period | (22 | ) | (26 | ) | |||
Decrease in notes receivable for the issuance of common stock | 1 | 4 | |||||
Balance, end of period | (21 | ) | (22 | ) | |||
Total CNA Stockholders’ Equity | 12,660 | 11,735 | |||||
Noncontrolling Interests | |||||||
Balance, beginning of period, as previously reported | — | 570 | |||||
Cumulative effect adjustment from accounting change for deferred acquisition costs, net of tax | — | (7 | ) | ||||
Balance, beginning of period, as adjusted | — | 563 | |||||
Net income | — | 15 | |||||
Other comprehensive income | — | 8 | |||||
Acquisition of CNA Surety noncontrolling interest | — | (429 | ) | ||||
Other | — | (12 | ) | ||||
Balance, end of period | — | 145 | |||||
Total Equity | $ | 12,660 | $ | 11,880 |
(In millions) | Acquisition Date | ||
July 2, 2012 | |||
Investments: | |||
Fixed maturity securities | $ | 117 | |
Short term investments | 255 | ||
Total investments | 372 | ||
Cash | 34 | ||
Reinsurance receivables | 252 | ||
Insurance receivables | 222 | ||
Accrued investment income | 2 | ||
Property and equipment | 4 | ||
Goodwill and other intangible assets | 171 | ||
Other assets | 109 | ||
Total assets acquired | $ | 1,166 | |
Claim and claim adjustment expenses | $ | 500 | |
Unearned premiums | 249 | ||
Long term debt | 30 | ||
Other liabilities | 156 | ||
Total liabilities assumed | $ | 935 |
(In millions) | Amount | Economic Useful Life | |||
Syndicate capacity | $ | 55 | Indefinite | ||
Total indefinite-lived intangible assets | 55 | ||||
Value of business acquired | 60 | 1 - 4 years | |||
Trade name | 8 | 8 years | |||
Distribution channel | 13 | 15 years | |||
Total finite-lived intangible assets | 81 | ||||
Total intangible assets as of the acquisition date | $ | 136 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Fixed maturity securities | $ | 507 | $ | 494 | $ | 1,528 | $ | 1,505 | |||||||
Short term investments | 2 | 2 | 5 | 6 | |||||||||||
Limited partnership investments | 89 | (93 | ) | 184 | 32 | ||||||||||
Equity securities | 4 | 4 | 10 | 16 | |||||||||||
Mortgage loans | 5 | 2 | 13 | 6 | |||||||||||
Trading portfolio (a) | 7 | (1 | ) | 18 | 5 | ||||||||||
Other | — | 1 | 3 | 6 | |||||||||||
Gross investment income | 614 | 409 | 1,761 | 1,576 | |||||||||||
Investment expense | (13 | ) | (15 | ) | (42 | ) | (45 | ) | |||||||
Net investment income | $ | 601 | $ | 394 | $ | 1,719 | $ | 1,531 |
(a) | There were no net unrealized gains (losses) related to changes in fair value of trading securities still held included in net investment income for the three or nine months ended September 30, 2012. Net unrealized losses related to changes in fair value on trading securities still held included in net investment income were $1 million for the three and nine months ended September 30, 2011. |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Net realized investment gains (losses): | |||||||||||||||
Fixed maturity securities: | |||||||||||||||
Gross realized gains | $ | 75 | $ | 56 | $ | 193 | $ | 233 | |||||||
Gross realized losses | (49 | ) | (85 | ) | (120 | ) | (222 | ) | |||||||
Net realized investment gains (losses) on fixed maturity securities | 26 | (29 | ) | 73 | 11 | ||||||||||
Equity securities: | |||||||||||||||
Gross realized gains | 5 | 1 | 10 | 7 | |||||||||||
Gross realized losses | (20 | ) | (2 | ) | (24 | ) | (10 | ) | |||||||
Net realized investment gains (losses) on equity securities | (15 | ) | (1 | ) | (14 | ) | (3 | ) | |||||||
Derivatives | (1 | ) | 1 | (1 | ) | — | |||||||||
Short term investments and other (a) (b) | (2 | ) | 2 | 8 | (7 | ) | |||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | $ | 8 | $ | (27 | ) | $ | 66 | $ | 1 |
(a) | The nine months ended September 30, 2011 included a $9 million loss related to the early extinguishment of debt in 2011. |
(b) | Includes net unrealized gains (losses) related to changes in the fair value of securities for which the fair value option has been elected. There were no net unrealized gains (losses) included in the three months ended September 30, 2012 or 2011 or the nine months ended September 30, 2012. There were $1 million of net unrealized gains for the nine months ended September 30, 2011. |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||
Corporate and other bonds | $ | 7 | $ | 49 | $ | 23 | $ | 73 | |||||||
States, municipalities and political subdivisions | 17 | — | 17 | — | |||||||||||
Asset-backed: | |||||||||||||||
Residential mortgage-backed | 20 | 21 | 49 | 95 | |||||||||||
Other asset-backed | — | 4 | — | 4 | |||||||||||
Total asset-backed | 20 | 25 | 49 | 99 | |||||||||||
U.S. Treasury and obligation of government-sponsored enterprises | — | — | 1 | — | |||||||||||
Total fixed maturity securities available-for-sale | 44 | 74 | 90 | 172 | |||||||||||
Equity securities available-for-sale: | |||||||||||||||
Common stock | 1 | 3 | 5 | 7 | |||||||||||
Preferred stock | 19 | — | 19 | 1 | |||||||||||
Total equity securities available-for-sale | 20 | 3 | 24 | 8 | |||||||||||
Net OTTI losses recognized in earnings | $ | 64 | $ | 77 | $ | 114 | $ | 180 |
September 30, 2012 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | Unrealized OTTI Losses (Gains) | ||||||||||||||
(In millions) | |||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||
Corporate and other bonds | $ | 19,209 | $ | 2,634 | $ | 32 | $ | 21,811 | $ | — | |||||||||
States, municipalities and political subdivisions | 9,415 | 1,450 | 53 | 10,812 | — | ||||||||||||||
Asset-backed: | |||||||||||||||||||
Residential mortgage-backed | 5,907 | 264 | 81 | 6,090 | (12 | ) | |||||||||||||
Commercial mortgage-backed | 1,582 | 123 | 17 | 1,688 | (3 | ) | |||||||||||||
Other asset-backed | 944 | 23 | 1 | 966 | — | ||||||||||||||
Total asset-backed | 8,433 | 410 | 99 | 8,744 | (15 | ) | |||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 182 | 11 | 1 | 192 | — | ||||||||||||||
Foreign government | 588 | 26 | — | 614 | — | ||||||||||||||
Redeemable preferred stock | 101 | 14 | — | 115 | — | ||||||||||||||
Total fixed maturity securities available-for-sale | 37,928 | 4,545 | 185 | 42,288 | $ | (15 | ) | ||||||||||||
Total fixed maturity securities trading | 17 | — | — | 17 | |||||||||||||||
Equity securities available-for-sale: | |||||||||||||||||||
Common stock | 22 | 24 | — | 46 | |||||||||||||||
Preferred stock | 206 | 8 | — | 214 | |||||||||||||||
Total equity securities available-for-sale | 228 | 32 | — | 260 | |||||||||||||||
Total | $ | 38,173 | $ | 4,577 | $ | 185 | $ | 42,565 |
December 31, 2011 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | Unrealized OTTI Losses (Gains) | ||||||||||||||
(In millions) | |||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||
Corporate and other bonds | $ | 19,086 | $ | 1,946 | $ | 154 | $ | 20,878 | $ | — | |||||||||
States, municipalities and political subdivisions | 9,018 | 900 | 136 | 9,782 | — | ||||||||||||||
Asset-backed: | |||||||||||||||||||
Residential mortgage-backed | 5,786 | 172 | 183 | 5,775 | 99 | ||||||||||||||
Commercial mortgage-backed | 1,365 | 48 | 59 | 1,354 | (2 | ) | |||||||||||||
Other asset-backed | 946 | 13 | 4 | 955 | — | ||||||||||||||
Total asset-backed | 8,097 | 233 | 246 | 8,084 | 97 | ||||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 479 | 14 | — | 493 | — | ||||||||||||||
Foreign government | 608 | 28 | — | 636 | — | ||||||||||||||
Redeemable preferred stock | 51 | 7 | — | 58 | — | ||||||||||||||
Total fixed maturity securities available-for-sale | 37,339 | 3,128 | 536 | 39,931 | $ | 97 | |||||||||||||
Total fixed maturity securities trading | 6 | — | — | 6 | |||||||||||||||
Equity securities available-for-sale: | |||||||||||||||||||
Common stock | 30 | 17 | — | 47 | |||||||||||||||
Preferred stock | 258 | 4 | 5 | 257 | |||||||||||||||
Total equity securities available-for-sale | 288 | 21 | 5 | 304 | |||||||||||||||
Total | $ | 37,633 | $ | 3,149 | $ | 541 | $ | 40,241 |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||
September 30, 2012 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||
(In millions) | |||||||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
Corporate and other bonds | $ | 600 | $ | 18 | $ | 210 | $ | 14 | $ | 810 | $ | 32 | |||||||||||
States, municipalities and political subdivisions | 84 | 1 | 227 | 52 | 311 | 53 | |||||||||||||||||
Asset-backed: | |||||||||||||||||||||||
Residential mortgage-backed | 327 | 3 | 580 | 78 | 907 | 81 | |||||||||||||||||
Commercial mortgage-backed | 142 | 2 | 132 | 15 | 274 | 17 | |||||||||||||||||
Other asset-backed | 66 | 1 | — | — | 66 | 1 | |||||||||||||||||
Total asset-backed | 535 | 6 | 712 | 93 | 1,247 | 99 | |||||||||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 22 | 1 | — | — | 22 | 1 | |||||||||||||||||
Total | $ | 1,241 | $ | 26 | $ | 1,149 | $ | 159 | $ | 2,390 | $ | 185 |
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||
December 31, 2011 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||
(In millions) | |||||||||||||||||||||||
Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
Corporate and other bonds | $ | 2,552 | $ | 126 | $ | 159 | $ | 28 | $ | 2,711 | $ | 154 | |||||||||||
States, municipalities and political subdivisions | 67 | 1 | 721 | 135 | 788 | 136 | |||||||||||||||||
Asset-backed: | |||||||||||||||||||||||
Residential mortgage-backed | 719 | 36 | 874 | 147 | 1,593 | 183 | |||||||||||||||||
Commercial mortgage-backed | 431 | 39 | 169 | 20 | 600 | 59 | |||||||||||||||||
Other asset-backed | 389 | 4 | — | — | 389 | 4 | |||||||||||||||||
Total asset-backed | 1,539 | 79 | 1,043 | 167 | 2,582 | 246 | |||||||||||||||||
Total fixed maturity securities available-for-sale | 4,158 | 206 | 1,923 | 330 | 6,081 | 536 | |||||||||||||||||
Equity securities available-for-sale: | |||||||||||||||||||||||
Preferred stock | 117 | 5 | — | — | 117 | 5 | |||||||||||||||||
Total | $ | 4,275 | $ | 211 | $ | 1,923 | $ | 330 | $ | 6,198 | $ | 541 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Beginning balance of credit losses on fixed maturity securities | $ | 99 | $ | 82 | $ | 92 | $ | 141 | |||||||
Additional credit losses for securities for which an OTTI loss was previously recognized | 2 | 11 | 23 | 29 | |||||||||||
Credit losses for securities for which an OTTI loss was not previously recognized | — | 10 | 2 | 11 | |||||||||||
Reductions for securities sold during the period | (3 | ) | (4 | ) | (11 | ) | (50 | ) | |||||||
Reductions for securities the Company intends to sell or more likely than not will be required to sell | — | — | (8 | ) | (32 | ) | |||||||||
Ending balance of credit losses on fixed maturity securities | $ | 98 | $ | 99 | $ | 98 | $ | 99 |
September 30, 2012 | December 31, 2011 | ||||||||||||||
(In millions) | Cost or Amortized Cost | Estimated Fair Value | Cost or Amortized Cost | Estimated Fair Value | |||||||||||
Due in one year or less | $ | 1,861 | $ | 1,876 | $ | 1,802 | $ | 1,812 | |||||||
Due after one year through five years | 13,382 | 14,176 | 13,110 | 13,537 | |||||||||||
Due after five years through ten years | 8,490 | 9,337 | 8,410 | 8,890 | |||||||||||
Due after ten years | 14,195 | 16,899 | 14,017 | 15,692 | |||||||||||
Total | $ | 37,928 | $ | 42,288 | $ | 37,339 | $ | 39,931 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Without hedge designation | |||||||||||||||
Currency forwards | $ | (1 | ) | $ | — | $ | (1 | ) | $ | (1 | ) | ||||
Forward commitments for mortgage-backed securities | — | 1 | — | 1 | |||||||||||
Total without hedge designation | (1 | ) | 1 | (1 | ) | — | |||||||||
Trading activities | |||||||||||||||
Futures sold, not yet purchased | (1 | ) | — | — | — | ||||||||||
Total | $ | (2 | ) | $ | 1 | $ | (1 | ) | $ | — |
September 30, 2012 | Contractual/ Notional Amount | Estimated Fair Value | |||||||||
(In millions) | Asset | (Liability) | |||||||||
Without hedge designation | |||||||||||
Credit default swaps - purchased protection | $ | 20 | $ | — | $ | (1 | ) | ||||
Currency forwards | 72 | — | (2 | ) | |||||||
Equity warrants | 5 | — | — | ||||||||
Total | $ | 97 | $ | — | $ | (3 | ) |
December 31, 2011 | Contractual/ Notional Amount | Estimated Fair Value | |||||||||
(In millions) | Asset | (Liability) | |||||||||
Without hedge designation | |||||||||||
Credit default swaps - purchased protection | $ | 20 | $ | — | $ | (1 | ) | ||||
Currency forwards | 22 | 1 | — | ||||||||
Equity warrants | 4 | — | — | ||||||||
Total | $ | 46 | $ | 1 | $ | (1 | ) |
September 30, 2012 | Total Assets/(Liabilities) at Fair Value | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||
Assets | |||||||||||||||
Fixed maturity securities: | |||||||||||||||
Corporate and other bonds | $ | — | $ | 21,569 | $ | 259 | $ | 21,828 | |||||||
States, municipalities and political subdivisions | — | 10,723 | 89 | 10,812 | |||||||||||
Asset-backed: | |||||||||||||||
Residential mortgage-backed | — | 5,653 | 437 | 6,090 | |||||||||||
Commercial mortgage-backed | — | 1,571 | 117 | 1,688 | |||||||||||
Other asset-backed | — | 595 | 371 | 966 | |||||||||||
Total asset-backed | — | 7,819 | 925 | 8,744 | |||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 168 | 24 | — | 192 | |||||||||||
Foreign government | 139 | 475 | — | 614 | |||||||||||
Redeemable preferred stock | 29 | 60 | 26 | 115 | |||||||||||
Total fixed maturity securities | 336 | 40,670 | 1,299 | 42,305 | |||||||||||
Equity securities | 98 | 112 | 50 | 260 | |||||||||||
Derivative and other financial instruments, included in Other invested assets | — | — | 11 | 11 | |||||||||||
Short term investments | 1,209 | 1,223 | 8 | 2,440 | |||||||||||
Life settlement contracts, included in Other assets | — | — | 113 | 113 | |||||||||||
Separate account business | 4 | 338 | 3 | 345 | |||||||||||
Total assets | $ | 1,647 | $ | 42,343 | $ | 1,484 | $ | 45,474 | |||||||
Liabilities | |||||||||||||||
Derivative financial instruments, included in Other liabilities | $ | — | $ | (2 | ) | $ | (1 | ) | $ | (3 | ) | ||||
Total liabilities | $ | — | $ | (2 | ) | $ | (1 | ) | $ | (3 | ) |
December 31, 2011 | Total Assets/(Liabilities) at Fair Value | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||
Assets | |||||||||||||||
Fixed maturity securities: | |||||||||||||||
Corporate and other bonds | $ | — | $ | 20,402 | $ | 482 | $ | 20,884 | |||||||
States, municipalities and political subdivisions | — | 9,611 | 171 | 9,782 | |||||||||||
Asset-backed: | |||||||||||||||
Residential mortgage-backed | — | 5,323 | 452 | 5,775 | |||||||||||
Commercial mortgage-backed | — | 1,295 | 59 | 1,354 | |||||||||||
Other asset-backed | — | 612 | 343 | 955 | |||||||||||
Total asset-backed | — | 7,230 | 854 | 8,084 | |||||||||||
U.S. Treasury and obligations of government-sponsored enterprises | 451 | 42 | — | 493 | |||||||||||
Foreign government | 92 | 544 | — | 636 | |||||||||||
Redeemable preferred stock | 5 | 53 | — | 58 | |||||||||||
Total fixed maturity securities | 548 | 37,882 | 1,507 | 39,937 | |||||||||||
Equity securities | 124 | 113 | 67 | 304 | |||||||||||
Derivative and other financial instruments, included in Other invested assets | — | 1 | 11 | 12 | |||||||||||
Short term investments | 1,106 | 508 | 27 | 1,641 | |||||||||||
Life settlement contracts, included in Other assets | — | — | 117 | 117 | |||||||||||
Separate account business | 21 | 373 | 23 | 417 | |||||||||||
Total assets | $ | 1,799 | $ | 38,877 | $ | 1,752 | $ | 42,428 | |||||||
Liabilities | |||||||||||||||
Derivative financial instruments, included in Other liabilities | $ | — | $ | — | $ | (1 | ) | $ | (1 | ) | |||||
Total liabilities | $ | — | $ | — | $ | (1 | ) | $ | (1 | ) |
Level 3 (In millions) | Balance at July 1, 2012 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at September 30, 2012 | Unrealized gains (losses) on Level 3 assets and liabilities held at September 30, 2012 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 488 | $ | 1 | $ | (4 | ) | $ | 50 | $ | (5 | ) | $ | (11 | ) | $ | — | $ | (260 | ) | $ | 259 | $ | (1 | ) | ||||||||||||||
States, municipalities and political subdivisions | 89 | — | — | — | — | — | — | — | 89 | — | |||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 443 | (17 | ) | 20 | 21 | — | (8 | ) | — | (22 | ) | 437 | (18 | ) | |||||||||||||||||||||||||
Commercial mortgage-backed | 166 | 4 | 6 | 12 | — | (17 | ) | 11 | (65 | ) | 117 | — | |||||||||||||||||||||||||||
Other asset-backed | 434 | 2 | 5 | 143 | (117 | ) | (34 | ) | — | (62 | ) | 371 | — | ||||||||||||||||||||||||||
Total asset-backed | 1,043 | (11 | ) | 31 | 176 | (117 | ) | (59 | ) | 11 | (149 | ) | 925 | (18 | ) | ||||||||||||||||||||||||
Redeemable preferred stock | 27 | — | (1 | ) | — | — | — | — | — | 26 | — | ||||||||||||||||||||||||||||
Total fixed maturity securities | 1,647 | (10 | ) | 26 | 226 | (122 | ) | (70 | ) | 11 | (409 | ) | 1,299 | (19 | ) | ||||||||||||||||||||||||
Equity securities | 93 | (19 | ) | (10 | ) | — | — | — | — | (14 | ) | 50 | (19 | ) | |||||||||||||||||||||||||
Derivative and other financial instruments, net | 10 | — | — | — | — | — | — | — | 10 | — | |||||||||||||||||||||||||||||
Short term investments | 4 | — | — | 7 | (4 | ) | — | 1 | — | 8 | — | ||||||||||||||||||||||||||||
Life settlement contracts | 116 | 7 | — | — | — | (10 | ) | — | — | 113 | — | ||||||||||||||||||||||||||||
Separate account business | 3 | — | — | — | — | — | — | — | 3 | — | |||||||||||||||||||||||||||||
Total | $ | 1,873 | $ | (22 | ) | $ | 16 | $ | 233 | $ | (126 | ) | $ | (80 | ) | $ | 12 | $ | (423 | ) | $ | 1,483 | $ | (38 | ) |
Level 3 (In millions) | Balance at July 1, 2011 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at September 30, 2011 | Unrealized gains (losses) on Level 3 assets and liabilities held at September 30, 2011 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 812 | $ | (7 | ) | $ | (3 | ) | $ | 113 | $ | (107 | ) | $ | (47 | ) | $ | 12 | $ | (154 | ) | $ | 619 | $ | (10 | ) | |||||||||||||
States, municipalities and political subdivisions | 179 | — | — | 3 | — | — | — | — | 182 | — | |||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 687 | 1 | (5 | ) | 73 | (81 | ) | (13 | ) | — | (31 | ) | 631 | — | |||||||||||||||||||||||||
Commercial mortgage-backed | 95 | — | (7 | ) | 76 | — | — | — | (5 | ) | 159 | — | |||||||||||||||||||||||||||
Other asset-backed | 491 | (5 | ) | (6 | ) | 114 | (105 | ) | (25 | ) | 2 | (37 | ) | 429 | (4 | ) | |||||||||||||||||||||||
Total asset-backed | 1,273 | (4 | ) | (18 | ) | 263 | (186 | ) | (38 | ) | 2 | (73 | ) | 1,219 | (4 | ) | |||||||||||||||||||||||
Total fixed maturity securities | 2,264 | (11 | ) | (21 | ) | 379 | (293 | ) | (85 | ) | 14 | (227 | ) | 2,020 | (14 | ) | |||||||||||||||||||||||
Equity securities | 36 | — | — | — | (1 | ) | — | — | (3 | ) | 32 | — | |||||||||||||||||||||||||||
Derivative and other financial instruments, net | 9 | (1 | ) | — | 1 | — | — | — | — | 9 | — | ||||||||||||||||||||||||||||
Short term investments | 6 | — | — | — | — | — | — | — | 6 | — | |||||||||||||||||||||||||||||
Life settlement contracts | 129 | 11 | — | — | — | (15 | ) | — | — | 125 | (1 | ) | |||||||||||||||||||||||||||
Separate account business | 37 | — | — | — | (2 | ) | — | — | — | 35 | — | ||||||||||||||||||||||||||||
Total | $ | 2,481 | $ | (1 | ) | $ | (21 | ) | $ | 380 | $ | (296 | ) | $ | (100 | ) | $ | 14 | $ | (230 | ) | $ | 2,227 | $ | (15 | ) |
Level 3 (In millions) | Balance at January 1, 2012 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at September 30, 2012 | Unrealized gains (losses) on Level 3 assets and liabilities held at September 30, 2012 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 482 | $ | 7 | $ | 2 | $ | 197 | $ | (118 | ) | $ | (43 | ) | $ | 42 | $ | (310 | ) | $ | 259 | $ | (1 | ) | |||||||||||||||
States, municipalities and political subdivisions | 171 | — | 3 | — | — | (85 | ) | — | — | 89 | — | ||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 452 | (15 | ) | (2 | ) | 81 | — | (24 | ) | — | (55 | ) | 437 | (18 | ) | ||||||||||||||||||||||||
Commercial mortgage-backed | 59 | 6 | 14 | 141 | (12 | ) | (21 | ) | 11 | (81 | ) | 117 | — | ||||||||||||||||||||||||||
Other asset-backed | 343 | 8 | 8 | 501 | (293 | ) | (93 | ) | — | (103 | ) | 371 | — | ||||||||||||||||||||||||||
Total asset-backed | 854 | (1 | ) | 20 | 723 | (305 | ) | (138 | ) | 11 | (239 | ) | 925 | (18 | ) | ||||||||||||||||||||||||
Redeemable preferred stock | — | — | (1 | ) | 53 | (26 | ) | — | — | — | 26 | — | |||||||||||||||||||||||||||
Total fixed maturity securities | 1,507 | 6 | 24 | 973 | (449 | ) | (266 | ) | 53 | (549 | ) | 1,299 | (19 | ) | |||||||||||||||||||||||||
Equity securities | 67 | (19 | ) | 6 | 26 | (16 | ) | — | — | (14 | ) | 50 | (21 | ) | |||||||||||||||||||||||||
Derivative and other financial instruments, net | 10 | — | — | — | — | — | — | — | 10 | — | |||||||||||||||||||||||||||||
Short term investments | 27 | — | — | 23 | (4 | ) | (39 | ) | 1 | — | 8 | — | |||||||||||||||||||||||||||
Life settlement contracts | 117 | 30 | — | — | — | (34 | ) | — | — | 113 | 3 | ||||||||||||||||||||||||||||
Separate account business | 23 | — | — | — | (20 | ) | — | — | — | 3 | — | ||||||||||||||||||||||||||||
Total | $ | 1,751 | $ | 17 | $ | 30 | $ | 1,022 | $ | (489 | ) | $ | (339 | ) | $ | 54 | $ | (563 | ) | $ | 1,483 | $ | (37 | ) |
Level 3 (In millions) | Balance at January 1, 2011 | Net realized investment gains (losses) and net change in unrealized appreciation (depreciation) included in net income (loss)* | Net change in unrealized appreciation (depreciation) included in other comprehensive income (loss) | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance at September 30, 2011 | Unrealized gains (losses) on Level 3 assets and liabilities held at September 30, 2011 recognized in net income (loss)* | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ | 624 | $ | (5 | ) | $ | (6 | ) | $ | 459 | $ | (157 | ) | $ | (144 | ) | $ | 52 | $ | (204 | ) | $ | 619 | $ | (11 | ) | |||||||||||||
States, municipalities and political subdivisions | 266 | — | — | 3 | — | (87 | ) | — | — | 182 | — | ||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed | 767 | (11 | ) | 9 | 170 | (164 | ) | (54 | ) | — | (86 | ) | 631 | (15 | ) | ||||||||||||||||||||||||
Commercial mortgage-backed | 73 | 3 | 11 | 81 | (4 | ) | — | — | (5 | ) | 159 | — | |||||||||||||||||||||||||||
Other asset-backed | 359 | — | (6 | ) | 441 | (236 | ) | (80 | ) | 2 | (51 | ) | 429 | (4 | ) | ||||||||||||||||||||||||
Total asset-backed | 1,199 | (8 | ) | 14 | 692 | (404 | ) | (134 | ) | 2 | (142 | ) | 1,219 | (19 | ) | ||||||||||||||||||||||||
Redeemable preferred stock | 3 | 3 | (3 | ) | — | (3 | ) | — | — | — | — | — | |||||||||||||||||||||||||||
Total fixed maturity securities | 2,092 | (10 | ) | 5 | 1,154 | (564 | ) | (365 | ) | 54 | (346 | ) | 2,020 | (30 | ) | ||||||||||||||||||||||||
Equity securities | 26 | (2 | ) | (1 | ) | 19 | (12 | ) | — | 5 | (3 | ) | 32 | (3 | ) | ||||||||||||||||||||||||
Derivative and other financial instruments, net | 25 | 2 | — | 1 | (19 | ) | — | — | — | 9 | 1 | ||||||||||||||||||||||||||||
Short term investments | 27 | — | — | 12 | — | (23 | ) | — | (10 | ) | 6 | — | |||||||||||||||||||||||||||
Life settlement contracts | 129 | 20 | — | — | — | (24 | ) | — | — | 125 | 2 | ||||||||||||||||||||||||||||
Separate account business | 41 | — | — | — | (6 | ) | — | — | — | 35 | — | ||||||||||||||||||||||||||||
Total | $ | 2,340 | $ | 10 | $ | 4 | $ | 1,186 | $ | (601 | ) | $ | (412 | ) | $ | 59 | $ | (359 | ) | $ | 2,227 | $ | (30 | ) |
Major Category of Assets and Liabilities | Consolidated Statements of Operations Line Items | |
Fixed maturity securities available-for-sale | Net realized investment gains (losses) | |
Fixed maturity securities trading | Net investment income | |
Equity securities | Net realized investment gains (losses) | |
Derivative financial instruments held in a trading portfolio | Net investment income | |
Derivative financial instruments not held in a trading portfolio and fair value option financial instruments | Net realized investment gains (losses) | |
Life settlement contracts | Other revenues |
Fair Value at September 30, 2012 | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | ||||||
Assets | |||||||||
(In millions) | |||||||||
Fixed maturity securities | $ | 98 | Discounted cash flow | Expected call date | 3.6 - 5.6 years (4.6 years) | ||||
$ | 61 | Market approach | Private offering price | $60.00 - $105.00 ($101.49) | |||||
Equity securities | $ | 33 | Market approach | Private offering price | $0.10 - $3,842.00 per share ($583.95 per share) | ||||
$ | 17 | Income approach | EBITDA projection (1) | $80 million | |||||
EBITDA multiple (1) | 1.82 | ||||||||
Life settlement contracts | $ | 113 | Discounted cash flow | Discount rate risk premium | 9% | ||||
Mortality assumption | 65% - 928% (185%) |
September 30, 2012 | Carrying Amount | Estimated Fair Value | |||||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||
Financial assets | |||||||||||||||||||
Notes receivable for the issuance of common stock | $ | 21 | $ | — | $ | — | $ | 21 | $ | 21 | |||||||||
Mortgage loans | 358 | — | — | 374 | 374 | ||||||||||||||
Financial liabilities | |||||||||||||||||||
Premium deposits and annuity contracts | $ | 103 | $ | — | $ | — | $ | 108 | $ | 108 | |||||||||
Short term debt | 13 | — | 13 | — | 13 | ||||||||||||||
Long term debt | 2,557 | — | 2,986 | — | 2,986 |
December 31, 2011 | Carrying Amount | Estimated Fair Value | |||||
(In millions) | |||||||
Financial assets | |||||||
Notes receivable for the issuance of common stock | $ | 22 | $ | 22 | |||
Mortgage loans | 234 | 247 | |||||
Financial liabilities | |||||||
Premium deposits and annuity contracts | $ | 109 | $ | 114 | |||
Short term debt | 83 | 84 | |||||
Long term debt | 2,525 | 2,679 |
Three months ended September 30, 2012 | CNA Specialty | CNA Commercial | Hardy | Corporate & Other Non-Core | Total | ||||||||||||||
(In millions) | |||||||||||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (39 | ) | $ | 2 | $ | (6 | ) | $ | 3 | $ | (40 | ) | ||||||
Pretax (favorable) unfavorable premium development | (1 | ) | (5 | ) | — | (1 | ) | (7 | ) | ||||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (40 | ) | $ | (3 | ) | $ | (6 | ) | $ | 2 | $ | (47 | ) |
Three months ended September 30, 2011 | CNA Specialty | CNA Commercial | Corporate & Other Non-Core | Total | |||||||||||
(In millions) | |||||||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (5 | ) | $ | (42 | ) | $ | 11 | $ | (36 | ) | ||||
Pretax (favorable) unfavorable premium development | (26 | ) | (11 | ) | 1 | (36 | ) | ||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (31 | ) | $ | (53 | ) | $ | 12 | $ | (72 | ) |
Nine months ended September 30, 2012 | CNA Specialty | CNA Commercial | Hardy | Corporate & Other Non-Core | Total | ||||||||||||||
(In millions) | |||||||||||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (80 | ) | $ | (25 | ) | $ | (6 | ) | $ | 1 | $ | (110 | ) | |||||
Pretax (favorable) unfavorable premium development | (15 | ) | (41 | ) | — | 1 | (55 | ) | |||||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (95 | ) | $ | (66 | ) | $ | (6 | ) | $ | 2 | $ | (165 | ) |
Nine months ended September 30, 2011 | CNA Specialty | CNA Commercial | Corporate & Other Non-Core | Total | |||||||||||
(In millions) | |||||||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (72 | ) | $ | (99 | ) | $ | 5 | $ | (166 | ) | ||||
Pretax (favorable) unfavorable premium development | (34 | ) | 21 | — | (13 | ) | |||||||||
Total pretax (favorable) unfavorable net prior year development | $ | (106 | ) | $ | (78 | ) | $ | 5 | $ | (179 | ) |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development: | |||||||||||||||
Medical Professional Liability | $ | 9 | $ | (18 | ) | $ | (6 | ) | $ | (52 | ) | ||||
Other Professional Liability | 1 | 1 | (1 | ) | (20 | ) | |||||||||
Surety | (60 | ) | 1 | (59 | ) | (2 | ) | ||||||||
Warranty | — | — | (1 | ) | (12 | ) | |||||||||
Other | 11 | 11 | (13 | ) | 14 | ||||||||||
Total pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | (39 | ) | $ | (5 | ) | $ | (80 | ) | $ | (72 | ) |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development: | |||||||||||||||
Commercial Auto | $ | 9 | $ | (2 | ) | $ | 11 | $ | (36 | ) | |||||
General Liability | (21 | ) | 4 | (26 | ) | 26 | |||||||||
Workers' Compensation | 24 | 3 | 13 | 39 | |||||||||||
Property and Other | (10 | ) | (47 | ) | (23 | ) | (128 | ) | |||||||
Total pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development | $ | 2 | $ | (42 | ) | $ | (25 | ) | $ | (99 | ) |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Pension cost (benefit) | |||||||||||||||
Service cost | $ | 3 | $ | 3 | $ | 9 | $ | 10 | |||||||
Interest cost on projected benefit obligation | 34 | 37 | 101 | 110 | |||||||||||
Expected return on plan assets | (43 | ) | (44 | ) | (128 | ) | (130 | ) | |||||||
Amortization of net actuarial (gain) loss | 10 | 7 | 29 | 19 | |||||||||||
Net periodic pension cost (benefit) | $ | 4 | $ | 3 | $ | 11 | $ | 9 | |||||||
Postretirement cost (benefit) | |||||||||||||||
Interest cost on projected benefit obligation | $ | 1 | $ | 1 | $ | 2 | $ | 3 | |||||||
Amortization of prior service credit | (4 | ) | (5 | ) | (13 | ) | (14 | ) | |||||||
Net periodic postretirement cost (benefit) | $ | (3 | ) | $ | (4 | ) | $ | (11 | ) | $ | (11 | ) |
Three months ended | |||||||||||||||||||||||||||
September 30, 2012 | CNA Specialty | CNA Commercial | Hardy | Life & Group Non-Core | Corporate & Other Non-Core | ||||||||||||||||||||||
(In millions) | Eliminations | Total | |||||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||||||
Net earned premiums | $ | 738 | $ | 840 | $ | 64 | $ | 141 | $ | (2 | ) | $ | — | $ | 1,781 | ||||||||||||
Net investment income | 159 | 230 | 2 | 201 | 9 | — | 601 | ||||||||||||||||||||
Other revenues | 58 | 11 | — | 1 | 7 | (1 | ) | 76 | |||||||||||||||||||
Total operating revenues | 955 | 1,081 | 66 | 343 | 14 | (1 | ) | 2,458 | |||||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||||||
Net incurred claims and benefits | 460 | 591 | 21 | 350 | 8 | — | 1,430 | ||||||||||||||||||||
Policyholders’ dividends | 1 | 3 | — | 1 | — | — | 5 | ||||||||||||||||||||
Amortization of deferred acquisition costs | 156 | 151 | 20 | 6 | — | — | 333 | ||||||||||||||||||||
Other insurance related expenses | 73 | 146 | 13 | 35 | 1 | — | 268 | ||||||||||||||||||||
Other expenses | 53 | 7 | 7 | 8 | 42 | (1 | ) | 116 | |||||||||||||||||||
Total claims, benefits and expenses | 743 | 898 | 61 | 400 | 51 | (1 | ) | 2,152 | |||||||||||||||||||
Operating income (loss) from continuing operations before income tax | 212 | 183 | 5 | (57 | ) | (37 | ) | — | 306 | ||||||||||||||||||
Income tax (expense) benefit on operating income (loss) | (76 | ) | (58 | ) | (2 | ) | 35 | 11 | — | (90 | ) | ||||||||||||||||
Net operating income (loss) from continuing operations attributable to CNA | 136 | 125 | 3 | (22 | ) | (26 | ) | — | 216 | ||||||||||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | 2 | 10 | (1 | ) | (3 | ) | — | — | 8 | ||||||||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (2 | ) | (3 | ) | — | 1 | 1 | — | (3 | ) | |||||||||||||||||
Net realized investment gains (losses) attributable to CNA | — | 7 | (1 | ) | (2 | ) | 1 | — | 5 | ||||||||||||||||||
Net income (loss) from continuing operations attributable to CNA | $ | 136 | $ | 132 | $ | 2 | $ | (24 | ) | $ | (25 | ) | $ | — | $ | 221 |
Three months ended | |||||||||||||||||||||||
September 30, 2011 | CNA Specialty | CNA Commercial | Life & Group Non-Core | Corporate & Other Non-Core | Total | ||||||||||||||||||
(In millions) | Eliminations | ||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||
Net earned premiums | $ | 741 | $ | 848 | $ | 142 | $ | 2 | $ | (1 | ) | $ | 1,732 | ||||||||||
Net investment income | 85 | 115 | 190 | 4 | — | 394 | |||||||||||||||||
Other revenues | 56 | 14 | 6 | — | — | 76 | |||||||||||||||||
Total operating revenues | 882 | 977 | 338 | 6 | (1 | ) | 2,202 | ||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||
Net incurred claims and benefits | 485 | 583 | 332 | (1 | ) | — | 1,399 | ||||||||||||||||
Policyholders’ dividends | (4 | ) | 3 | 2 | — | — | 1 | ||||||||||||||||
Amortization of deferred acquisition costs | 147 | 145 | 5 | — | — | 297 | |||||||||||||||||
Other insurance related expenses | 75 | 141 | 36 | 1 | (1 | ) | 252 | ||||||||||||||||
Other expenses | 48 | 10 | 2 | 42 | — | 102 | |||||||||||||||||
Total claims, benefits and expenses | 751 | 882 | 377 | 42 | (1 | ) | 2,051 | ||||||||||||||||
Operating income (loss) from continuing operations before income tax | 131 | 95 | (39 | ) | (36 | ) | — | 151 | |||||||||||||||
Income tax (expense) benefit on operating income (loss) | (48 | ) | (46 | ) | 25 | 11 | — | (58 | ) | ||||||||||||||
Net operating (income) loss, after-tax, attributable to noncontrolling interests | — | (2 | ) | — | — | — | (2 | ) | |||||||||||||||
Net operating income (loss) from continuing operations attributable to CNA | 83 | 47 | (14 | ) | (25 | ) | — | 91 | |||||||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | (8 | ) | (15 | ) | (4 | ) | — | — | (27 | ) | |||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | 3 | 5 | 1 | 1 | — | 10 | |||||||||||||||||
Net realized investment (gains) losses, after-tax, attributable to noncontrolling interests | — | 1 | — | — | — | 1 | |||||||||||||||||
Net realized investment gains (losses) attributable to CNA | (5 | ) | (9 | ) | (3 | ) | 1 | — | (16 | ) | |||||||||||||
Net income (loss) from continuing operations attributable to CNA | $ | 78 | $ | 38 | $ | (17 | ) | $ | (24 | ) | $ | — | $ | 75 |
Nine months ended | |||||||||||||||||||||||||||
September 30, 2012 | CNA Specialty | CNA Commercial | Hardy (a) | Life & Group Non-Core | Corporate & Other Non-Core | ||||||||||||||||||||||
(In millions) | Eliminations | Total | |||||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||||||
Net earned premiums | $ | 2,163 | $ | 2,452 | $ | 64 | $ | 421 | $ | (1 | ) | $ | (1 | ) | $ | 5,098 | |||||||||||
Net investment income | 446 | 646 | 2 | 600 | 25 | — | 1,719 | ||||||||||||||||||||
Other revenues | 171 | 31 | — | 15 | 14 | (1 | ) | 230 | |||||||||||||||||||
Total operating revenues | 2,780 | 3,129 | 66 | 1,036 | 38 | (2 | ) | 7,047 | |||||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||||||
Net incurred claims and benefits | 1,376 | 1,749 | 21 | 1,009 | (5 | ) | — | 4,150 | |||||||||||||||||||
Policyholders’ dividends | — | 9 | — | 5 | — | — | 14 | ||||||||||||||||||||
Amortization of deferred acquisition costs | 458 | 437 | 20 | 22 | — | — | 937 | ||||||||||||||||||||
Other insurance related expenses | 222 | 425 | 13 | 106 | 1 | (1 | ) | 766 | |||||||||||||||||||
Other expenses | 153 | 24 | 7 | 18 | 137 | (1 | ) | 338 | |||||||||||||||||||
Total claims, benefits and expenses | 2,209 | 2,644 | 61 | 1,160 | 133 | (2 | ) | 6,205 | |||||||||||||||||||
Operating income (loss) from continuing operations before income tax | 571 | 485 | 5 | (124 | ) | (95 | ) | — | 842 | ||||||||||||||||||
Income tax (expense) benefit on operating income (loss) | (197 | ) | (164 | ) | (2 | ) | 86 | 29 | — | (248 | ) | ||||||||||||||||
Net operating income (loss) from continuing operations attributable to CNA | 374 | 321 | 3 | (38 | ) | (66 | ) | — | 594 | ||||||||||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | 18 | 34 | (1 | ) | 14 | 1 | — | 66 | |||||||||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (6 | ) | (12 | ) | — | (5 | ) | — | — | (23 | ) | ||||||||||||||||
Net realized investment gains (losses) attributable to CNA | 12 | 22 | (1 | ) | 9 | 1 | — | 43 | |||||||||||||||||||
Net income (loss) from continuing operations attributable to CNA | $ | 386 | $ | 343 | $ | 2 | $ | (29 | ) | $ | (65 | ) | $ | — | $ | 637 |
September 30, 2012 | |||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||
Reinsurance receivables | $ | 750 | $ | 1,131 | $ | 238 | $ | 1,297 | $ | 2,498 | $ | — | $ | 5,914 | |||||||||||||
Insurance receivables | $ | 676 | $ | 1,108 | $ | 206 | $ | 10 | $ | 4 | $ | — | $ | 2,004 | |||||||||||||
Deferred acquisition costs | $ | 306 | $ | 278 | $ | 19 | $ | — | $ | — | $ | — | $ | 603 | |||||||||||||
Insurance reserves | |||||||||||||||||||||||||||
Claim and claim adjustment expenses | $ | 6,853 | $ | 11,226 | $ | 466 | $ | 2,956 | $ | 2,830 | $ | — | $ | 24,331 | |||||||||||||
Unearned premiums | 1,698 | 1,604 | 243 | 137 | — | (1 | ) | 3,681 | |||||||||||||||||||
Future policy benefits | — | — | — | 10,974 | — | — | 10,974 | ||||||||||||||||||||
Policyholders’ funds | 13 | 13 | — | 139 | — | — | 165 |
(a) | Included from date of acquisition. |
Nine months ended | |||||||||||||||||||||||
September 30, 2011 | CNA Specialty | CNA Commercial | Life & Group Non-Core | Corporate & Other Non-Core | Total | ||||||||||||||||||
(In millions) | Eliminations | ||||||||||||||||||||||
Operating revenues | |||||||||||||||||||||||
Net earned premiums | $ | 2,098 | $ | 2,418 | $ | 427 | $ | 1 | $ | (2 | ) | $ | 4,942 | ||||||||||
Net investment income | 371 | 569 | 567 | 24 | — | 1,531 | |||||||||||||||||
Other revenues | 164 | 40 | 6 | 4 | — | 214 | |||||||||||||||||
Total operating revenues | 2,633 | 3,027 | 1,000 | 29 | (2 | ) | 6,687 | ||||||||||||||||
Claims, Benefits and Expenses | |||||||||||||||||||||||
Net incurred claims and benefits | 1,333 | 1,807 | 985 | — | — | 4,125 | |||||||||||||||||
Policyholders’ dividends | (4 | ) | 5 | 5 | — | — | 6 | ||||||||||||||||
Amortization of deferred acquisition costs | 428 | 435 | 17 | — | — | 880 | |||||||||||||||||
Other insurance related expenses | 216 | 400 | 108 | 4 | (2 | ) | 726 | ||||||||||||||||
Other expenses | 140 | 37 | 14 | 129 | — | 320 | |||||||||||||||||
Total claims, benefits and expenses | 2,113 | 2,684 | 1,129 | 133 | (2 | ) | 6,057 | ||||||||||||||||
Operating income (loss) from continuing operations before income tax | 520 | 343 | (129 | ) | (104 | ) | — | 630 | |||||||||||||||
Income tax (expense) benefit on operating income (loss) | (182 | ) | (127 | ) | 78 | 34 | — | (197 | ) | ||||||||||||||
Net operating (income) loss, after-tax, attributable to noncontrolling interests | (12 | ) | (3 | ) | — | — | — | (15 | ) | ||||||||||||||
Net operating income (loss) from continuing operations attributable to CNA | 326 | 213 | (51 | ) | (70 | ) | — | 418 | |||||||||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | 7 | 13 | (7 | ) | (12 | ) | — | 1 | |||||||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (2 | ) | (4 | ) | 2 | 5 | — | 1 | |||||||||||||||
Net realized investment (gains) losses, after-tax, attributable to noncontrolling interests | — | — | — | — | — | — | |||||||||||||||||
Net realized investment gains (losses) attributable to CNA | 5 | 9 | (5 | ) | (7 | ) | — | 2 | |||||||||||||||
Net income (loss) from continuing operations attributable to CNA | $ | 331 | $ | 222 | $ | (56 | ) | $ | (77 | ) | $ | — | $ | 420 |
December 31, 2011 | |||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Reinsurance receivables | $ | 852 | $ | 1,188 | $ | 1,375 | $ | 2,677 | $ | — | $ | 6,092 | |||||||||||
Insurance receivables | $ | 670 | $ | 1,047 | $ | 8 | $ | 1 | $ | — | $ | 1,726 | |||||||||||
Deferred acquisition costs | $ | 300 | $ | 252 | $ | — | $ | — | $ | — | $ | 552 | |||||||||||
Insurance reserves | |||||||||||||||||||||||
Claim and claim adjustment expenses | $ | 6,840 | $ | 11,509 | $ | 2,825 | $ | 3,129 | $ | — | $ | 24,303 | |||||||||||
Unearned premiums | 1,629 | 1,480 | 141 | — | — | 3,250 | |||||||||||||||||
Future policy benefits | — | — | 9,810 | — | — | 9,810 | |||||||||||||||||
Policyholders’ funds | 15 | 10 | 166 | — | — | 191 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
CNA Specialty | |||||||||||||||
International | $ | 53 | $ | 54 | $ | 163 | $ | 159 | |||||||
Professional & Management Liability | 700 | 623 | 2,039 | 1,909 | |||||||||||
Surety | 124 | 123 | 364 | 353 | |||||||||||
Warranty & Alternative Risks | 80 | 74 | 232 | 219 | |||||||||||
CNA Specialty revenues | 957 | 874 | 2,798 | 2,640 | |||||||||||
CNA Commercial | |||||||||||||||
CNA Select Risk | 70 | 65 | 208 | 203 | |||||||||||
Commercial Insurance | 756 | 622 | 2,188 | 2,015 | |||||||||||
International | 93 | 133 | 274 | 390 | |||||||||||
Small Business | 172 | 142 | 493 | 432 | |||||||||||
CNA Commercial revenues | 1,091 | 962 | 3,163 | 3,040 | |||||||||||
Hardy revenues | 65 | 65 | |||||||||||||
Life & Group Non-Core | |||||||||||||||
Health | 274 | 274 | 852 | 818 | |||||||||||
Life & Annuity | 64 | 55 | 181 | 170 | |||||||||||
Other | 2 | 5 | 17 | 5 | |||||||||||
Life & Group Non-Core revenues | 340 | 334 | 1,050 | 993 | |||||||||||
Corporate & Other Non-Core revenues | 14 | 6 | 39 | 17 | |||||||||||
Eliminations | (1 | ) | (1 | ) | (2 | ) | (2 | ) | |||||||
Total revenues | $ | 2,466 | $ | 2,175 | $ | 7,113 | $ | 6,688 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Operating Revenues | |||||||||||||||
Net earned premiums | $ | 1,781 | $ | 1,732 | $ | 5,098 | $ | 4,942 | |||||||
Net investment income | 601 | 394 | 1,719 | 1,531 | |||||||||||
Other revenues | 76 | 76 | 230 | 214 | |||||||||||
Total operating revenues | 2,458 | 2,202 | 7,047 | 6,687 | |||||||||||
Claims, Benefits and Expenses | |||||||||||||||
Net incurred claims and benefits | 1,430 | 1,399 | 4,150 | 4,125 | |||||||||||
Policyholders' dividends | 5 | 1 | 14 | 6 | |||||||||||
Amortization of deferred acquisition costs | 333 | 297 | 937 | 880 | |||||||||||
Other insurance related expenses | 268 | 252 | 766 | 726 | |||||||||||
Other expenses | 116 | 102 | 338 | 320 | |||||||||||
Total claims, benefits and expenses | 2,152 | 2,051 | 6,205 | 6,057 | |||||||||||
Operating income (loss) from continuing operations before income tax | 306 | 151 | 842 | 630 | |||||||||||
Income tax (expense) benefit on operating income (loss) | (90 | ) | (58 | ) | (248 | ) | (197 | ) | |||||||
Net operating (income) loss, after-tax, attributable to noncontrolling interests | — | (2 | ) | — | (15 | ) | |||||||||
Net operating income (loss) from continuing operations attributable to CNA | 216 | 91 | 594 | 418 | |||||||||||
Net realized investment gains (losses), net of participating policyholders' interests | 8 | (27 | ) | 66 | 1 | ||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (3 | ) | 10 | (23 | ) | 1 | |||||||||
Net realized investment (gains) losses, after-tax, attributable to noncontrolling interests | — | 1 | — | — | |||||||||||
Net realized investment gains (losses) attributable to CNA | 5 | (16 | ) | 43 | 2 | ||||||||||
Income (loss) from continuing operations attributable to CNA | 221 | 75 | 637 | 420 | |||||||||||
Loss from discontinued operations attributable to CNA | — | — | — | (1 | ) | ||||||||||
Net income (loss) attributable to CNA | $ | 221 | $ | 75 | $ | 637 | $ | 419 |
• | Insurance Reserves |
• | Reinsurance and Insurance Receivables |
• | Valuation of Investments and Impairment of Securities |
• | Long Term Care Products and Payout Annuity Contracts |
• | Pension and Postretirement Benefit Obligations |
• | Income Taxes |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions, except ratios) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Net written premiums | $ | 723 | $ | 750 | $ | 2,206 | $ | 2,172 | |||||||
Net earned premiums | 738 | 741 | 2,163 | 2,098 | |||||||||||
Net investment income | 159 | 85 | 446 | 371 | |||||||||||
Net operating income (loss) | 136 | 83 | 374 | 326 | |||||||||||
Net realized investment gains (losses), after-tax | — | (5 | ) | 12 | 5 | ||||||||||
Net income (loss) | 136 | 78 | 386 | 331 | |||||||||||
Ratios | |||||||||||||||
Loss and loss adjustment expense | 62.5 | % | 65.5 | % | 63.6 | % | 63.6 | % | |||||||
Expense | 31.0 | 29.8 | 31.5 | 30.6 | |||||||||||
Dividend | 0.2 | (0.6 | ) | — | (0.2 | ) | |||||||||
Combined | 93.7 | % | 94.7 | % | 95.1 | % | 94.0 | % |
(In millions) | September 30, 2012 | December 31, 2011 | |||||
Gross Case Reserves | $ | 2,435 | $ | 2,441 | |||
Gross IBNR Reserves | 4,418 | 4,399 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 6,853 | $ | 6,840 | |||
Net Case Reserves | $ | 2,112 | $ | 2,086 | |||
Net IBNR Reserves | 4,010 | 3,937 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 6,122 | $ | 6,023 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions, except ratios) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Net written premiums | $ | 811 | $ | 836 | $ | 2,543 | $ | 2,544 | |||||||
Net earned premiums | 840 | 848 | 2,452 | 2,418 | |||||||||||
Net investment income | 230 | 115 | 646 | 569 | |||||||||||
Net operating income (loss) | 125 | 47 | 321 | 213 | |||||||||||
Net realized investment gains (losses), after-tax | 7 | (9 | ) | 22 | 9 | ||||||||||
Net income (loss) | 132 | 38 | 343 | 222 | |||||||||||
Ratios | |||||||||||||||
Loss and loss adjustment expense | 70.5 | % | 68.7 | % | 71.3 | % | 74.7 | % | |||||||
Expense | 35.2 | 33.8 | 35.2 | 34.6 | |||||||||||
Dividend | 0.3 | 0.4 | 0.3 | 0.2 | |||||||||||
Combined | 106.0 | % | 102.9 | % | 106.8 | % | 109.5 | % |
September 30, 2012 | December 31, 2011 | ||||||
(In millions) | |||||||
Gross Case Reserves | $ | 6,129 | $ | 6,266 | |||
Gross IBNR Reserves | 5,097 | 5,243 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 11,226 | $ | 11,509 | |||
Net Case Reserves | $ | 5,604 | $ | 5,720 | |||
Net IBNR Reserves | 4,536 | 4,670 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 10,140 | $ | 10,390 |
Period ended September 30 | Three Months | ||
(In millions, except ratios) | 2012 | ||
Net written premiums | $ | 56 | |
Net earned premiums | 64 | ||
Net investment income | 2 | ||
Net operating income (loss) | 3 | ||
Net realized investment gains (losses), after-tax | (1 | ) | |
Net income (loss) | 2 | ||
Ratios | |||
Loss and loss adjustment expense | 33.3 | % | |
Expense | 52.5 | ||
Dividend | — | ||
Combined | 85.8 | % |
September 30, 2012 | |||
(In millions) | |||
Gross Case Reserves | $ | 341 | |
Gross IBNR Reserves | 125 | ||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 466 | |
Net Case Reserves | $ | 188 | |
Net IBNR Reserves | 77 | ||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 265 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Net earned premiums | $ | 141 | $ | 142 | $ | 421 | $ | 427 | |||||||
Net investment income | 201 | 190 | 600 | 567 | |||||||||||
Net operating income (loss) | (22 | ) | (14 | ) | (38 | ) | (51 | ) | |||||||
Net realized investment gains (losses), after-tax | (2 | ) | (3 | ) | 9 | (5 | ) | ||||||||
Net income (loss) | (24 | ) | (17 | ) | (29 | ) | (56 | ) |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Net investment income | $ | 9 | $ | 4 | $ | 25 | $ | 24 | |||||||
Net operating income (loss) | (26 | ) | (25 | ) | (66 | ) | (70 | ) | |||||||
Net realized investment gains (losses), after-tax | 1 | 1 | 1 | (7 | ) | ||||||||||
Net income (loss) | (25 | ) | (24 | ) | (65 | ) | (77 | ) |
September 30, 2012 | December 31, 2011 | ||||||
(In millions) | |||||||
Gross Case Reserves | $ | 1,234 | $ | 1,321 | |||
Gross IBNR Reserves | 1,596 | 1,808 | |||||
Total Gross Carried Claim and Claim Adjustment Expense Reserves | $ | 2,830 | $ | 3,129 | |||
Net Case Reserves | $ | 310 | $ | 347 | |||
Net IBNR Reserves | 231 | 244 | |||||
Total Net Carried Claim and Claim Adjustment Expense Reserves | $ | 541 | $ | 591 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Fixed maturity securities | $ | 507 | $ | 494 | $ | 1,528 | $ | 1,505 | |||||||
Short term investments | 2 | 2 | 5 | 6 | |||||||||||
Limited partnership investments | 89 | (93 | ) | 184 | 32 | ||||||||||
Equity securities | 4 | 4 | 10 | 16 | |||||||||||
Mortgage loans | 5 | 2 | 13 | 6 | |||||||||||
Trading portfolio | 7 | (1 | ) | 18 | 5 | ||||||||||
Other | — | 1 | 3 | 6 | |||||||||||
Gross investment income | 614 | 409 | 1,761 | 1,576 | |||||||||||
Investment expense | (13 | ) | (15 | ) | (42 | ) | (45 | ) | |||||||
Net investment income | $ | 601 | $ | 394 | $ | 1,719 | $ | 1,531 |
Periods ended September 30 | Three Months | Nine Months | |||||||||||||
(In millions) | 2012 | 2011 | 2012 | 2011 | |||||||||||
Fixed maturity securities: | |||||||||||||||
Corporate and other bonds | $ | 48 | $ | (28 | ) | $ | 91 | $ | 63 | ||||||
States, municipalities and political subdivisions | (16 | ) | 13 | 11 | 3 | ||||||||||
Asset-backed | (7 | ) | (15 | ) | (36 | ) | (62 | ) | |||||||
U.S. Treasury and obligations of government-sponsored enterprises | 1 | — | 3 | 1 | |||||||||||
Foreign government | — | 1 | 4 | 3 | |||||||||||
Redeemable preferred stock | — | — | — | 3 | |||||||||||
Total fixed maturity securities | 26 | (29 | ) | 73 | 11 | ||||||||||
Equity securities | (15 | ) | (1 | ) | (14 | ) | (3 | ) | |||||||
Derivative securities | (1 | ) | 1 | (1 | ) | — | |||||||||
Short term investments and other | (2 | ) | 2 | 8 | (7 | ) | |||||||||
Net realized investment gains (losses), net of participating policyholders’ interests | 8 | (27 | ) | 66 | 1 | ||||||||||
Income tax (expense) benefit on net realized investment gains (losses) | (3 | ) | 10 | (23 | ) | 1 | |||||||||
Net realized investment (gains) losses, after-tax, attributable to noncontrolling interests | — | 1 | — | — | |||||||||||
Net realized investment gains (losses) attributable to CNA | $ | 5 | $ | (16 | ) | $ | 43 | $ | 2 |
September 30, 2012 | December 31, 2011 | ||||||||||||
(In millions) | % | % | |||||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ | 4,743 | 11 | % | $ | 4,760 | 12 | % | |||||
AAA rated | 3,362 | 8 | 3,421 | 8 | |||||||||
AA and A rated | 19,274 | 45 | 17,807 | 45 | |||||||||
BBB rated | 11,788 | 28 | 10,790 | 27 | |||||||||
Non-investment grade | 3,138 | 8 | 3,159 | 8 | |||||||||
Total | $ | 42,305 | 100 | % | $ | 39,937 | 100 | % |
September 30, 2012 | December 31, 2011 | ||||||||||||
(In millions) | % | % | |||||||||||
BB | $ | 1,448 | 46 | % | $ | 1,484 | 47 | % | |||||
B | 762 | 24 | 867 | 27 | |||||||||
CCC - C | 707 | 23 | 689 | 22 | |||||||||
D | 221 | 7 | 119 | 4 | |||||||||
Total | $ | 3,138 | 100 | % | $ | 3,159 | 100 | % |
September 30, 2012 | Estimated Fair Value | % | Gross Unrealized Losses | % | |||||||||
(In millions) | |||||||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ | 453 | 19 | % | $ | 46 | 25 | % | |||||
AAA | 200 | 8 | 5 | 3 | |||||||||
AA | 350 | 15 | 54 | 29 | |||||||||
A | 305 | 13 | 11 | 6 | |||||||||
BBB | 519 | 22 | 29 | 16 | |||||||||
Non-Investment Grade | 563 | 23 | 40 | 21 | |||||||||
Total | $ | 2,390 | 100 | % | $ | 185 | 100 | % |
September 30, 2012 | Estimated Fair Value | % | Gross Unrealized Losses | % | |||||||||
Due in one year or less | $ | 218 | 9 | % | $ | 14 | 8 | % | |||||
Due after one year through five years | 802 | 34 | 24 | 13 | |||||||||
Due after five years through ten years | 763 | 32 | 76 | 41 | |||||||||
Due after ten years | 607 | 25 | 71 | 38 | |||||||||
Total | $ | 2,390 | 100 | % | $ | 185 | 100 | % |
September 30, 2012 | December 31, 2011 | ||||||||||||
(In millions) | Fair Value | Effective Duration (In years) | Fair Value | Effective Duration (In years) | |||||||||
Investments supporting Life & Group Non-Core | $ | 15,261 | 11.4 | $ | 13,820 | 11.5 | |||||||
Other interest sensitive investments | 29,070 | 3.8 | 28,071 | 3.9 | |||||||||
Total | $ | 44,331 | 6.5 | $ | 41,891 | 6.4 |
September 30, 2012 | December 31, 2011 | ||||||
(In millions) | |||||||
Short term investments: | |||||||
Commercial paper | $ | 1,167 | $ | 411 | |||
U.S. Treasury securities | 593 | 903 | |||||
Money market funds | 433 | 45 | |||||
Other | 291 | 282 | |||||
Total short term investments | $ | 2,484 | $ | 1,641 |
September 30, 2012 | Corporate | Sovereign | Total | ||||||||||||
(In millions) | Financial Sector | Other Sectors | |||||||||||||
AAA | $ | 212 | $ | 70 | $ | 120 | $ | 402 | |||||||
AA | 217 | 115 | 31 | 363 | |||||||||||
A | 909 | 712 | 5 | 1,626 | |||||||||||
BBB | 312 | 1,079 | 7 | 1,398 | |||||||||||
Non-investment grade | 33 | 217 | — | 250 | |||||||||||
Total fair value | $ | 1,683 | $ | 2,193 | $ | 163 | $ | 4,039 | |||||||
Total amortized cost | $ | 1,598 | $ | 1,941 | $ | 159 | $ | 3,698 |
• | the risks and uncertainties associated with our loss reserves, as outlined in the Critical Accounting Estimates and the Reserves - Estimates and Uncertainties sections of our Annual Report on Form 10-K, including the sufficiency of the reserves and the possibility for future increases, which would be reflected in the results of operations in the period that the need for such adjustment is determined; |
• | the risk that the other parties to the transaction in which, subject to certain limitations, we ceded our legacy A&EP liabilities will not fully perform their obligations to CNA, the uncertainty in estimating loss reserves for A&EP liabilities and the possible continued exposure of CNA to liabilities for A&EP claims that are not covered under the terms of the transaction; |
• | the performance of reinsurance companies under reinsurance contracts with us; and |
• | the consummation of contemplated transactions and the successful integration of acquired operations. |
• | the impact of competitive products, policies and pricing and the competitive environment in which we operate, including changes in our book of business; |
• | product and policy availability and demand and market responses, including the level of ability to obtain rate increases and decline or non-renew under priced accounts, to achieve premium targets and profitability and to realize growth and retention estimates; |
• | general economic and business conditions, including recessionary conditions that may decrease the size and number of our insurance customers and create additional losses to our lines of business, especially those that provide management and professional liability insurance, as well as surety bonds, to businesses engaged in real estate, financial services and professional services, and inflationary pressures on medical care costs, construction costs and other economic sectors that increase the severity of claims; |
• | conditions in the capital and credit markets, including continuing uncertainty and instability in these markets, as well as the overall economy, and their impact on the returns, types, liquidity and valuation of our investments; |
• | conditions in the capital and credit markets that may limit our ability to raise significant amounts of capital on favorable terms, as well as restrictions on the ability or willingness of Loews to provide additional capital support to us; and |
• | the possibility of changes in our ratings by ratings agencies, including the inability to access certain markets or distribution channels and the required collateralization of future payment obligations as a result of such changes, and changes in rating agency policies and practices. |
• | regulatory initiatives and compliance with governmental regulations, judicial interpretations within the regulatory framework, including interpretation of policy provisions, decisions regarding coverage and theories of liability, trends in litigation and the outcome of any litigation involving us, and rulings and changes in tax laws and regulations; |
• | regulatory limitations, impositions and restrictions upon us, including the effects of assessments and other surcharges for guaranty funds and second-injury funds, other mandatory pooling arrangements and future assessments levied on insurance companies as well as the new federal financial regulatory reform of the insurance industry established by the Dodd-Frank Wall Street Reform and Consumer Protection Act; |
• | increased operating costs and underwriting losses arising from the Patient Protection and Affordable Care Act and the related amendments in the Health Care and Education Reconciliation Act, as well as health care reform proposals at the state level; and |
• | regulatory limitations and restrictions, including limitations upon our ability to receive dividends from our insurance subsidiaries, imposed by regulatory authorities, including regulatory capital adequacy standards. |
• | weather and other natural physical events, including the severity and frequency of storms, hail, snowfall and other winter conditions, natural disasters such as hurricanes and earthquakes, as well as climate change, including effects on weather patterns, greenhouse gases, sea, land and air temperatures, sea levels, rain and snow; |
• | regulatory requirements imposed by coastal state regulators in the wake of hurricanes or other natural disasters, including limitations on the ability to exit markets or to non-renew, cancel or change terms and conditions in policies, as well as mandatory assessments to fund any shortfalls arising from the inability of quasi-governmental insurers to pay claims; |
• | man-made disasters, including the possible occurrence of terrorist attacks and the effect of the absence or insufficiency of applicable terrorism legislation on coverages; |
• | the unpredictability of the nature, targets, severity or frequency of potential terrorist events, as well as the uncertainty as to our ability to contain our terrorism exposure effectively; and |
• | the occurrence of epidemics. |
CNA Financial Corporation | |||
Dated: | October 30, 2012 | By | /s/ D. Craig Mense |
D. Craig Mense Executive Vice President and Chief Financial Officer |
Description of Exhibit | Exhibit Number |
Certification of Chief Executive Officer | 31.1 |
Certification of Chief Financial Officer | 31.2 |
Written Statement of the Chief Executive Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.1 |
Written Statement of the Chief Financial Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.2 |
XBRL Instance Document | 101.INS |
XBRL Taxonomy Extension Schema | 101.SCH |
XBRL Taxonomy Extension Calculation Linkbase | 101.CAL |
XBRL Taxonomy Extension Definition Linkbase | 101.DEF |
XBRL Taxonomy Label Linkbase | 101.LAB |
XBRL Taxonomy Extension Presentation Linkbase | 101.PRE |
1. | I have reviewed this quarterly report on Form 10-Q of CNA Financial Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | October 30, 2012 | By | /s/ Thomas F. Motamed |
Thomas F. Motamed | |||
Chief Executive Officer |
1. | I have reviewed this quarterly report on Form 10-Q of CNA Financial Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | October 30, 2012 | By | /s/ D. Craig Mense |
D. Craig Mense | |||
Chief Financial Officer |
• | the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2012 filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | October 30, 2012 | By | /s/ Thomas F. Motamed |
Thomas F. Motamed | |||
Chief Executive Officer |
• | the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2012 filed on the date hereof with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | October 30, 2012 | By | /s/ D. Craig Mense |
D. Craig Mense | |||
Chief Financial Officer |
Investments (Contractual maturity) (Details) (USD $)
In Millions, unless otherwise specified |
Sep. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Cost or Amortized Cost | ||
Due in one year or less, cost or amortized cost | $ 1,861 | $ 1,802 |
Due after one year through five years, cost or amortized cost | 13,382 | 13,110 |
Due after five years through ten years, cost or amortized cost | 8,490 | 8,410 |
Due after ten years, cost or amortized cost | 14,195 | 14,017 |
Total amortized cost basis | 37,928 | 37,339 |
Estimated Fair Value | ||
Due in one year or less, estimated fair value | 1,876 | 1,812 |
Due after one year through five years, estimated fair value | 14,176 | 13,537 |
Due after five years through ten years, estimated fair value | 9,337 | 8,890 |
Due after ten years, estimated fair value | 16,899 | 15,692 |
Total estimated fair value | $ 42,288 | $ 39,931 |
Claim and Claim Adjustment Expense Reserves (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
Catastrophe losses net of reinsurance | $ 27 | $ 50 | $ 123 | $ 205 |
Investments (Net investment income) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
Gross investment income | $ 614 | $ 409 | $ 1,761 | $ 1,576 |
Investment expense | (13) | (15) | (42) | (45) |
Net investment income | 601 | 394 | 1,719 | 1,531 |
Fixed maturity securities [Member]
|
||||
Gross investment income | 507 | 494 | 1,528 | 1,505 |
Short term investments [Member]
|
||||
Gross investment income | 2 | 2 | 5 | 6 |
Limited partnership investments [Member]
|
||||
Gross investment income | 89 | (93) | 184 | 32 |
Equity securities [Member]
|
||||
Gross investment income | 4 | 4 | 10 | 16 |
Mortgage loans [Member]
|
||||
Gross investment income | 5 | 2 | 13 | 6 |
Trading portfolio [Member]
|
||||
Gross investment income | 7 | (1) | 18 | 5 |
Other [Member]
|
||||
Gross investment income | $ 1 | $ 3 | $ 6 |
Benefit Plans (Tables)
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of net periodic cost (benefit) | Net Periodic Cost (Benefit)
|
Claim and Claim Adjustment Expense Reserves (Net prior year claim and allocated claim adjustment expense reserve development for CNA Specialty segment) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development, excluding Life & Group | $ (40) | $ (36) | $ (110) | $ (166) |
CNA Specialty [Member]
|
||||
Medical Professional Liability | 9 | (18) | (6) | (52) |
Other Professional Liability | 1 | 1 | (1) | (20) |
Surety | (60) | 1 | (59) | (2) |
Warranty | (1) | (12) | ||
Other | 11 | 11 | (13) | 14 |
Pretax (favorable) unfavorable net prior year claim and allocated claim adjustment expense reserve development, excluding Life & Group | $ (39) | $ (5) | $ (80) | $ (72) |
Derivative Financial Instruments (Summary of aggregate contractual or notional amounts and gross estimated fair values related to derivative financial instruments) (Details) (USD $)
In Millions, unless otherwise specified |
Sep. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Without hedge designation [Member]
|
||
Contractual/notional amount | $ 97 | $ 46 |
Estimated fair value asset | 1 | |
Estimated fair value (liability) | (3) | (1) |
Without hedge designation [Member] | Credit default swaps - purchased protection [Member]
|
||
Contractual/notional amount | 20 | 20 |
Estimated fair value asset | ||
Estimated fair value (liability) | (1) | (1) |
Without hedge designation [Member] | Currency forwards [Member]
|
||
Contractual/notional amount | 72 | 22 |
Estimated fair value asset | 1 | |
Estimated fair value (liability) | (2) | |
Without hedge designation [Member] | Equity warrants [Member]
|
||
Contractual/notional amount | 5 | 4 |
Estimated fair value asset | ||
Estimated fair value (liability) |
Benefit Plans (Components of net periodic cost (benefit)) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
Pension Plans, Defined Benefit [Member]
|
||||
Defined Benefit Plan, Net Periodic Benefit Cost | ||||
Service cost | $ 3 | $ 3 | $ 9 | $ 10 |
Interest cost on projected benefit obligation | 34 | 37 | 101 | 110 |
Expected return on plan assets | (43) | (44) | (128) | (130) |
Amortization of net actuarial (gain) loss | 10 | 7 | 29 | 19 |
Net periodic postretirement (benefit) cost | 4 | 3 | 11 | 9 |
Other Postretirement Benefit Plans, Defined Benefit [Member]
|
||||
Defined Benefit Plan, Net Periodic Benefit Cost | ||||
Interest cost on projected benefit obligation | 1 | 1 | 2 | 3 |
Amortization of prior service credit | (4) | (5) | (13) | (14) |
Net periodic postretirement (benefit) cost | $ (3) | $ (4) | $ (11) | $ (11) |
Fair Value Fair Value (Narrative) (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
Fair Value, Level 2 to level 1 Transfers, Amount | $ 106 | $ 106 | ||
Fair Value, Level 1 to level 2 Transfers, Amount |
General
|
9 Months Ended |
---|---|
Sep. 30, 2012
|
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
General | Note A. General Basis of Presentation The Condensed Consolidated Financial Statements (Unaudited) include the accounts of CNA Financial Corporation (CNAF) and its controlled subsidiaries. Collectively, CNAF and its controlled subsidiaries are referred to as CNA or the Company. CNA’s property and casualty and remaining life and group insurance operations are primarily conducted by Continental Casualty Company (CCC), The Continental Insurance Company, Western Surety Company, and Continental Assurance Corporation. Loews Corporation (Loews) owned approximately 90% of the outstanding common stock of CNAF as of September 30, 2012. The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Certain financial information that is normally included in annual financial statements, including certain financial statement notes, prepared in accordance with GAAP, is not required for interim reporting purposes and has been condensed or omitted. These statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in CNAF's Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) for the year ended December 31, 2011, including the summary of significant accounting policies in Note A. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting periods. Actual results may differ from those estimates. The interim financial data as of September 30, 2012 and for the three and nine months ended September 30, 2012 and 2011 is unaudited. However, in the opinion of management, the interim data includes all adjustments, consisting of normal recurring accruals, necessary for a fair statement of the Company's results for the interim periods. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Intercompany amounts have been eliminated. Noncontrolling Interests Net income attributable to noncontrolling interests for the three and nine months ended September 30, 2011 represented the noncontrolling interests in CNA Surety Corporation (Surety) and First Insurance Company of Hawaii (FICOH). On June 10, 2011, CNA completed the acquisition of the noncontrolling interest of Surety and on November 29, 2011, CNA completed the sale of its 50% ownership interest in FICOH. Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts In October 2010, the Financial Accounting Standards Board issued updated accounting guidance which limits the capitalization of costs incurred to acquire or renew insurance contracts to those that are incremental direct costs of successful contract acquisitions. The previous guidance allowed the capitalization of acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance contracts, whether the costs related to successful or unsuccessful efforts. As of January 1, 2012, the Company adopted the updated accounting guidance prospectively as of January 1, 2004, the earliest date practicable. Due to the lack of available historical data related to certain accident and health contracts issued prior to January 1, 2004, a full retrospective application of the change in accounting guidance was impracticable. Acquisition costs capitalized prior to January 1, 2004 will continue to be accounted for under the previous accounting guidance and will be amortized over the premium-paying period of the related policies using assumptions consistent with those used for computing future policy benefit reserves for such contracts. For the three and nine months ended September 30, 2012, the adoption of the new accounting guidance resulted in no impact and a $3 million decrease in Net income attributable to CNA and no impact and a $0.01 decrease in Basic and Diluted earnings per share attributable to CNA common stockholders. The Company has adjusted its previously reported financial information included herein to reflect the change in accounting guidance for deferred acquisition costs. The impacts of adopting the new accounting standard on the Company's Condensed Consolidated Balance Sheet as of December 31, 2011 were a $106 million decrease in Deferred acquisition costs and a $37 million increase in Deferred income taxes. The impacts to Accumulated other comprehensive income (AOCI) and Additional paid-in capital were the result of the indirect effects of the Company's adoption of this guidance on Shadow Adjustments, as further discussed in Note D, and the Company's acquisition of the noncontrolling interest of Surety as discussed above. The impacts on the Company's Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2011 were a $59 million and $171 million decrease in Amortization of deferred acquisition costs, a $59 million and $178 million increase in Other operating expenses, a $1 million and $2 million decrease in Income tax expense, and a $1 million increase and no impact in Net income attributable to noncontrolling interests, resulting in no impact and a $5 million decrease in Net income attributable to CNA, and no impact and a $0.02 decrease in Basic and Diluted earnings per share attributable to CNA common stockholders. There were no changes to net cash flows from operating, investing or financing activities for the comparative periods presented as a result of the adoption of the new accounting standard. |